Clinical trial
Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass…
NCT00330772 · Hamilton Health Sciences Corporation, Other · Completed
Key facts
| NCT number | NCT00330772 |
|---|---|
| Title | Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study |
| Official title | Pilot Study of Preoperative Aspirin and Postoperative Clopidogrel's Effects on Graft Patency and Cardiac Events in Coronary Artery Bypass Surgery |
| Acronym | PAPA CABG |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Coronary Artery Bypass Grafting |
| Intervention type | Drug |
| Interventions | Aspirin, Clopidogrel |
| Enrollment | 150 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 29, 2006 |
| Last update posted | Aug 3, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: